JP2008150375A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008150375A5 JP2008150375A5 JP2007322260A JP2007322260A JP2008150375A5 JP 2008150375 A5 JP2008150375 A5 JP 2008150375A5 JP 2007322260 A JP2007322260 A JP 2007322260A JP 2007322260 A JP2007322260 A JP 2007322260A JP 2008150375 A5 JP2008150375 A5 JP 2008150375A5
- Authority
- JP
- Japan
- Prior art keywords
- iron
- release
- hemochromatosis
- intestine
- organs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 14
- 229910052742 iron Inorganic materials 0.000 description 7
- 208000018565 Hemochromatosis Diseases 0.000 description 2
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000010438 iron metabolism Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06126122A EP1932807A1 (en) | 2006-12-14 | 2006-12-14 | Inorganic compounds |
| EP06126101 | 2006-12-14 | ||
| EP06126101.2 | 2006-12-14 | ||
| EP06126122.8 | 2006-12-14 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008150375A JP2008150375A (ja) | 2008-07-03 |
| JP2008150375A5 true JP2008150375A5 (https=) | 2011-02-03 |
| JP5456969B2 JP5456969B2 (ja) | 2014-04-02 |
Family
ID=38983614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007322260A Active JP5456969B2 (ja) | 2006-12-14 | 2007-12-13 | 製造方法 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US8252310B2 (https=) |
| JP (1) | JP5456969B2 (https=) |
| KR (1) | KR20090094820A (https=) |
| AR (1) | AR064301A1 (https=) |
| AU (1) | AU2007331482B2 (https=) |
| BR (1) | BRPI0720272A2 (https=) |
| CA (1) | CA2671828C (https=) |
| CL (1) | CL2007003606A1 (https=) |
| EC (1) | ECSP099410A (https=) |
| ES (1) | ES2526171T3 (https=) |
| IL (1) | IL198548A0 (https=) |
| MA (1) | MA30993B1 (https=) |
| MX (1) | MX2009006307A (https=) |
| MY (1) | MY151047A (https=) |
| NO (1) | NO342285B1 (https=) |
| NZ (1) | NZ576672A (https=) |
| PE (1) | PE20081381A1 (https=) |
| PT (1) | PT2319804E (https=) |
| RU (1) | RU2447933C2 (https=) |
| SI (1) | SI2319804T1 (https=) |
| TN (1) | TN2009000214A1 (https=) |
| TW (1) | TWI465239B (https=) |
| WO (1) | WO2008071747A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9720061D0 (en) | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
| MY157620A (en) | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
| GB0714670D0 (en) | 2007-07-27 | 2007-09-05 | Ineos Healthcare Ltd | Use |
| GB0720220D0 (en) | 2007-10-16 | 2007-11-28 | Ineos Healthcare Ltd | Compound |
| TWI592159B (zh) | 2007-11-16 | 2017-07-21 | 威佛（國際）股份有限公司 | 藥學組成物 |
| JP2009292119A (ja) | 2008-06-09 | 2009-12-17 | Alps Electric Co Ltd | サーマルヘッド |
| KR20110018434A (ko) * | 2008-06-13 | 2011-02-23 | 노파르티스 아게 | 철 함유 인산염 흡착제의 제조를 위한 제조 방법 |
| GB0814326D0 (en) * | 2008-08-05 | 2008-09-10 | Medical Res Council | Phosphate binding materials and their uses |
| CN108938585A (zh) * | 2009-07-21 | 2018-12-07 | 凯克斯生物制药公司 | 柠檬酸铁剂型 |
| GB0913525D0 (en) | 2009-08-03 | 2009-09-16 | Ineos Healthcare Ltd | Method |
| GB201001779D0 (en) | 2010-02-04 | 2010-03-24 | Ineos Healthcare Ltd | Composition |
| DE102011112898A1 (de) | 2011-09-08 | 2013-03-14 | Charité - Universitätsmedizin Berlin | Nanopartikuläres Phosphatadsorbens basierend auf Maghämit oder Maghämit/Magnetit, dessen Herstellung und Verwendungen |
| WO2013056085A1 (en) * | 2011-10-13 | 2013-04-18 | Vidasym, Inc. | Iron-fiber composition, preparation and uses thereof |
| RU2496722C1 (ru) * | 2012-04-10 | 2013-10-27 | Леонид Асхатович Мазитов | Способ очистки сточной воды от фосфатов |
| US9796792B2 (en) | 2013-03-08 | 2017-10-24 | Vidasym, Inc. | Metal ion-functional fiber component complex compositions, preparation and uses thereof |
| US9339489B2 (en) * | 2013-03-15 | 2016-05-17 | Aprecia Pharmaceuticals Company | Rapid disperse dosage form containing levetiracetam |
| MX365513B (es) * | 2013-03-15 | 2019-06-06 | Aprecia Pharmaceuticals LLC | Forma de dosificacion de dispersion rapida que contiene levetiracetam. |
| PT3073997T (pt) * | 2013-11-27 | 2020-09-08 | Vifor Int Ag | Composição farmacêutica, compreendendo partículas de ligante de fosfato |
| EP3157516A4 (en) | 2014-06-22 | 2017-12-13 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof |
| US9901918B2 (en) | 2015-03-04 | 2018-02-27 | Graver Technologies Llc | Hybrid ion exchange material and method for making the same |
| CN105193844A (zh) * | 2015-05-27 | 2015-12-30 | 合肥川迪医药技术有限公司 | 用于制备含δ-羟基氧化铁(多核)及其药物组合物的方法及在高磷血症领域中的应用 |
| WO2017172633A1 (en) * | 2016-03-28 | 2017-10-05 | New Sky Energy Intellectual Property Holding Company, Llc | Methods of producing ferrihydrite nanoparticle slurries, and systems and products employing the same |
| EP3829761A1 (en) | 2018-07-30 | 2021-06-09 | Interquim S.A. | Process for preparing an adsorbent for phosphate in aqueous medium |
| US12329778B2 (en) | 2020-01-16 | 2025-06-17 | Vifor Fresenius Medical Care Renal Pharma Ltd | Particles of a mixture of iron(III)-oxyhydroxide, sucrose and one or more starches, preferably of sucroferric oxyhydroxide |
| CN115317494B (zh) * | 2022-07-22 | 2024-02-13 | 康瑞鑫(天津)药物研究院有限公司 | 高磷酸盐结合力的蔗糖氢氧化氧铁及其制备方法 |
| WO2025096992A1 (en) * | 2023-11-01 | 2025-05-08 | Navinta, Llc | Process for isolation of solid ferric derisomaltose |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2885393A (en) * | 1956-02-24 | 1959-05-05 | R K Laros Company | Dextran-iron complex and process for making same |
| US3697502A (en) * | 1969-11-03 | 1972-10-10 | Christensen Henry M | Method of making iron dextran-preparations |
| US3951821A (en) * | 1972-07-14 | 1976-04-20 | The Dow Chemical Company | Disintegrating agent for tablets |
| US4180567A (en) * | 1977-09-02 | 1979-12-25 | Pharmachem Corporation | Iron preparations and methods of making and administering the same |
| DE3026868C2 (de) * | 1980-07-16 | 1986-03-13 | Laboratorien Hausmann AG, St. Gallen | Verfahren zur Herstellung von Eisen(III)hydroxid-Dextran-Komplexen und sie enthaltende pharmazeutische sterile wäßrige Lösung |
| US4569836A (en) * | 1981-08-27 | 1986-02-11 | Gordon Robert T | Cancer treatment by intracellular hyperthermia |
| EP0330801A1 (en) * | 1983-02-08 | 1989-09-06 | Schering Aktiengesellschaft | Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease |
| DE3422249A1 (de) * | 1984-06-15 | 1985-12-19 | Pfeifer & Langen, 5000 Köln | Wasserloesliches eisendextran und verfahren zu seiner herstellung |
| DE3572440D1 (en) * | 1984-06-19 | 1989-09-28 | Basf Ag | Gastro-resistant cylindrical pancreatine-microtablets |
| US4827945A (en) * | 1986-07-03 | 1989-05-09 | Advanced Magnetics, Incorporated | Biologically degradable superparamagnetic materials for use in clinical applications |
| US5055288A (en) * | 1987-06-26 | 1991-10-08 | Advanced Magnetics, Inc. | Vascular magnetic imaging method and agent comprising biodegradeable superparamagnetic metal oxides |
| US4970079A (en) | 1989-06-05 | 1990-11-13 | Purdue Research Foundation | Method and composition of oxy-iron compounds for treatment of hyperphosphatemia |
| IL98744A0 (en) * | 1990-07-06 | 1992-07-15 | Gen Hospital Corp | Method of studying biological tissue using monocrystalline particles |
| SU1807606A1 (ru) * | 1991-03-29 | 1995-08-09 | Пермский политехнический институт | Способ получения анионообменника на основе гидроксида титана |
| US5234697A (en) * | 1992-06-22 | 1993-08-10 | Digestive Care Inc. | Compositions of gastric acid-resistant microspheres containing salts of bile acids |
| EP0585898B1 (en) | 1992-09-04 | 1998-08-05 | Mitsubishi Chemical Corporation | Process for the production and use of an anion exchange resin |
| DE4239442C2 (de) * | 1992-11-24 | 2001-09-13 | Sebo Gmbh | Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten |
| DE19547356A1 (de) * | 1995-12-19 | 1997-06-26 | Vifor Int Ag | Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung |
| US5906978A (en) * | 1996-08-14 | 1999-05-25 | Hemocleanse, Inc. | Method for iron delivery to a patient by transfer from dialysate |
| GB9720061D0 (en) | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
| DE10128511A1 (de) * | 2001-06-13 | 2002-12-19 | Sebo Gmbh | Verwendung eines Phosphatadsorbers gegen Gefäßerkrankungen |
| EP1457256A1 (en) | 2001-12-21 | 2004-09-15 | Muromachi Chemical Co., Ltd | Adsorbent for phosphoric acid |
| DE102004031181A1 (de) * | 2004-06-28 | 2006-01-19 | Vifor (International) Ag | Phosphatadsorbens |
-
2007
- 2007-12-05 PT PT111525846T patent/PT2319804E/pt unknown
- 2007-12-05 SI SI200731582T patent/SI2319804T1/sl unknown
- 2007-12-05 ES ES11152584.6T patent/ES2526171T3/es active Active
- 2007-12-10 US US12/001,132 patent/US8252310B2/en active Active
- 2007-12-12 AU AU2007331482A patent/AU2007331482B2/en active Active
- 2007-12-12 NZ NZ576672A patent/NZ576672A/en unknown
- 2007-12-12 MY MYPI20092071 patent/MY151047A/en unknown
- 2007-12-12 MX MX2009006307A patent/MX2009006307A/es active IP Right Grant
- 2007-12-12 BR BRPI0720272-5A patent/BRPI0720272A2/pt not_active Application Discontinuation
- 2007-12-12 AR ARP070105565A patent/AR064301A1/es not_active Application Discontinuation
- 2007-12-12 WO PCT/EP2007/063832 patent/WO2008071747A1/en not_active Ceased
- 2007-12-12 RU RU2009126614/05A patent/RU2447933C2/ru active
- 2007-12-12 PE PE2007001773A patent/PE20081381A1/es not_active Application Discontinuation
- 2007-12-12 CL CL200703606A patent/CL2007003606A1/es unknown
- 2007-12-12 KR KR1020097012145A patent/KR20090094820A/ko not_active Ceased
- 2007-12-12 CA CA2671828A patent/CA2671828C/en active Active
- 2007-12-13 TW TW096147736A patent/TWI465239B/zh active
- 2007-12-13 JP JP2007322260A patent/JP5456969B2/ja active Active
-
2009
- 2009-05-04 IL IL198548A patent/IL198548A0/en unknown
- 2009-05-29 TN TNP2009000214A patent/TN2009000214A1/fr unknown
- 2009-06-12 EC EC2009009410A patent/ECSP099410A/es unknown
- 2009-06-15 MA MA31992A patent/MA30993B1/fr unknown
- 2009-07-10 NO NO20092632A patent/NO342285B1/no unknown
-
2012
- 2012-02-03 US US13/365,349 patent/US20120126440A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008150375A5 (https=) | ||
| JP2011522896A5 (https=) | ||
| IL259851A (en) | Compounds and methods of inhibiting antidepressant nhe mediator in the treatment of disorders associated with fluid retention or overload of salts and gastrointestinal disorders | |
| JP2007521835A5 (https=) | ||
| EP2583978A3 (en) | Prevention and treatment of synucleinopathic and amyloidogenic disease | |
| Sharkey et al. | Use of antibodies and immunoconjugates for the therapy of more accessible cancers | |
| NZ589445A (en) | Rasagiline for parkinson's disease modification | |
| JP2009530288A5 (https=) | ||
| IL180565A0 (en) | An improved stopcock for administering medicaments into the patient's body | |
| IL229255A (en) | Use of sodium arsenite sodium to make a pharmacological preparation for tissue or organ rejection and treatment kit | |
| EP2200704A4 (en) | FILTER FACIAL RESPIRATOR WITH INTEGRATED FASTENERS IN THE BODY SUPPORT STRUCTURE OF A MASK | |
| MX2009008825A (es) | Nuevos metodos de terapia anticolinergica. | |
| WO2009002867A3 (en) | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement | |
| MX2009011357A (es) | Derivados de tetrahidropirido[4,3-d] pirimidinona y metodos de uso de los mismos. | |
| ZA200701584B (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | |
| ZA201104011B (en) | Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases | |
| WO2007012061A3 (en) | Prevention and treatment of synucleinopathic and amyloidogenic disease | |
| WO2007135426A3 (en) | Treatment of neurodegeneratives diseases | |
| GB0410399D0 (en) | The treatment of respiratory disease | |
| GB0410398D0 (en) | The treatment of respiratory disease | |
| SI2234631T1 (sl) | Spojine in postopki za zdravljenje ĺ˝ilne bolezni | |
| WO2007023154A3 (de) | EISEN(III)-KOMPLEXVERBINDtMGEN ZUR BEHANDLUNG VON EISENMANGEL-ZUSTÄNDEN BEI PATIENTEN MIT CHRONISCH-ENTZÜNDLICHER DARMERKRANKUNG | |
| MX2011009804A (es) | Una dosis de ave5026 para el tratamiento de tromboembolismo venoso en pacientes con deterioro renal severo. | |
| UA97440C2 (en) | Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease | |
| TW200626133A (en) | Oral medication for twice-daily administration |